Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | |
|---|---|---|---|---|---|
| Total revenue | 34.09%7.47B | 3.45B | 1.76B | 51.24%5.57B | 3.68B |
| Cost of revenue | 8.65%6.14B | 2.61B | 1.2B | 2.89%5.66B | 5.5B |
| Gross profit | 1,600.00%1.32B | 848M | 565M | 95.15%-88M | -1.81B |
| Operating expense | -0.20%2.46B | 589M | 655M | 7.41%2.46B | 2.29B |
| Selling and administrative expenses | 3.00%2.54B | --646M | --679M | 12.91%2.47B | --2.18B |
| -General and administrative expense | 3.00%2.54B | --646M | --679M | 12.91%2.47B | --2.18B |
| Other operating expenses | ---- | ---- | ---- | ---- | --110M |
| Total other operating income | 3,950.00%81M | --57M | ---- | --2M | --0 |
| Operating profit | 55.37%-1.14B | 259M | -90M | 37.88%-2.55B | -4.11B |
| Net non-operating interest income (expenses) | -27.87%-156M | -38M | -36M | 43.52%-122M | -216M |
| Non-operating interest income | -61.73%31M | --2M | --10M | --81M | --0 |
| Non-operating interest expense | -7.88%187M | --40M | --46M | -6.02%203M | --216M |
| Net investment income | -104.08%-10M | -72.93%245M | 905M | ||
| Gain(Loss) on financial instruments designated as cash flow hedges | |||||
| Gain(Loss) on derecognition of available-for-sale financial assets | |||||
| Income from associates and other participating interests | |||||
| Special income (charges) | 0 | -1.55B | 0 | ||
| Less:Impairment of capital assets | --0 | ---- | ---- | --1.6B | --0 |
| Less:Other special charges | ---- | ---- | ---- | ---45M | ---- |
| Other non-operating income (expenses) | -77.05%-108M | -93M | -2M | -90.63%-61M | -32M |
| Income before tax | 65.02%-1.41B | 116M | -121M | -17.06%-4.04B | -3.45B |
| Income tax | 1,512.50%129M | 122M | 1M | -97.46%8M | 315M |
| Net income | 61.88%-1.54B | -6M | -122M | -7.46%-4.05B | -3.77B |
| Net income continuous operations | 61.90%-1.54B | ---6M | ---122M | -7.48%-4.05B | ---3.77B |
| Noncontrolling interests | 0 | 0 | 0 | -99.71%1M | 347M |
| Net income attributable to the company | 61.87%-1.54B | -6M | -122M | 1.65%-4.05B | -4.12B |
| Preferred stock dividends | |||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 61.87%-1.54B | -6M | -122M | 1.65%-4.05B | -4.12B |
| Gross dividend payment | |||||
| Basic earnings per share | 62.00%-81.7765 | -0.254 | -5.1641 | 1.65%-215.2024 | -218.8165 |
| Diluted earnings per share | 62.00%-81.7765 | -0.254 | -5.1641 | 1.65%-215.2024 | -218.8165 |
| Dividend per share | |||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |